Providence Cancer Center Oncology

Portland, Oregon 97225

1 studies enrolling now · 2 studies all time

What they study most

Ovarian Cancer, Recurrent Glioblastoma

Studies at this site

• Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01) — Recruiting now
• Standard Chemotherapy vs. Chemotherapy Guided by Cancer Stem Cell Test in Recurrent Glioblastoma — Completed